References
- Sweet MBE, Thonar EJ-MA, Immelman AR, Solomon L: Biochemical changes in progressive osteoarthrosis. Ann Rheum Dis 1977: 36: 387–398.
- De Simone DP, Parsons DB, Johnson KE, Jacobs RP: Type II collagen-induced arthritis. A morphologic and biochemical study of articular cartilage. Arth Rheum 1983: 26: 1245–1258.
- Ali SY: The degradation of cartilage matrix by an intercellular protease. J Biochem 1964; 93: 611.
- Baici A, Salgam P, Fehr K, Boni A: Inhibition of human elastase from polymorphonuclear leucocytes by a GAG-polysulfate. Biochem Pharm 1979; 29: 1723–1727.
- Marossy K: Interaction of the chymotrypsin and elastase-like enzyme of the human granulocyte with glycosaminoglycans. Biochem Biophys Acta 1981: 659: 351–361.
- Montgomery R, Dryer RL, Conway TW and Spector AA: Biochemistry, 3rd ed, St. Louis: CV Mosby Co. 1980: 312–322.
- Stryer L: Biochemistry: 2nd ed. New York: WH Freeman and Co. 1981: 200–202.
- Roskoski R: Biochemistry: Philadelphia: WB Saunders Co., 1996: 479–482.
- Morreale P, Manopulo R, Galati M, Boccanera L, Saponati G, Bocchi L: Comparison of the anti-inflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis. J Rheum 1996; 23(8): 1385–1391.
- Rovetta G: Galactosaminoglycuronoglycan sulfate (matrix) in therapy of tibiofibular osteoarthritis of the knee. Drugs Exptl Clin Res 1991: 17: 52–57.
- Oliviero U, Sorrentino GP, De Paola P, Tranfaglia E, et al.: Effects of the treatment with Matrix on elderly people with chronic articular degeneration. Drugs Exptl Clin Res 1991; 17: 45–51.
- Drovanti A, Bignamini AA, Rovati AL: Therapeutic activity of oral glucosamine sulfate in osteoarthosis: a placebo-controlled double-blind investigation. Clin Therapeu 1980; 3: 260–272.
- D'Ambrosio E, Casa B, Bompani R, Scali G, Scali M: Glucosamine sulfate: a controlled clinical investigation in arthrosis. Pharmatherapeutica 1981; 2: 504–508.
- Hanson RR, Smalley LR, Huff GK, White S, Hammad TA: Oral treatment with a glucosamine-chondroitin sulfate compound for degenerative joint disease in horses: 25 cases. Equine Practice 1997; 19: 16–21.
- Setnikar I, Pacini MA, Revel L: Antiarthritic effects of glucosamine sulfate studied in animal models. Arzneim-Forsch/Drug Res 1991; 41: 542–545.
- Shankland WE: The effects of glucosamine and chondroitin sulfate on osteoarthritis of the TMJ: a preliminary report of 50 patients. J Craniomandib Pract 1998; 16: 230–235.
- Reading A E: Testing pain mechanisms in persons in pain. In: Wall PD, Melzack R: Textbook of pain. 2nd ed. Churchill Livingstone, 1989: 270.
- Fields HL: Pain. New York: McGraw-Hill, 1987: 219–220, 246–247.
- Simons DG, Travell JG, Simons LS: Travell & Simons' Myofascial pain and dysfunction. The trigger point manual. 2nd ed. Baltimore: Williams & Wilkins, 1999: 126–137, 150–166.
- Stegenga B, de Bont LGM, Boering G: Osteoarthrosis as the cause of craniomandibular pain and dysfunction: a unifying concept. J Oral Maxillofac Surg 1989; 47: 249.
- Dijkgraaf LC, de Bont LGM, Boering G, Liem RSB: The structure, biochemistry, and metabolism of osteoarthritic cartilage: a review of the literature. J Oral Maxillofac Surg 1995; 53: 1182–1192.
- Akeson WH, Amiel D, Gershuni DH: Articular cartilage physiology and metabolism. In: Resnick D: Diagnosis of bone and joint disorders. 3rd ed. Philadelphia: WB Saunders Co., 1995: 769–787.
- Hansson TL: Pathological aspects of arthritides and derangements. In: Sarnat BG, Laskin DM: The temporomandibular joint: a biological basis for clinical practice. 4th ed. Philadelphia: WB Saunders, 1992: 171–174.
- Parioli E. Glycosaminoglycan chondroprotection: pharmacological vistas. Int J Clinical Pharma Res 1993; 13 [Suppl]: 1–9.
- Chevallard M, Galanti A, Paresce E, Wolf A, Carrabba M: Efficacy and tolerability of galactosamino-glycuronoglycan-sulfate in osteoarthritis of the knee: an 11-month experience. Int J Clinical Pharma Res 1993: 13 [Suppl]: 49–53.
- Tapadinhas M, Rivera IC, Bignamini AA: Oral glucosamine sulphate in the management of arthrosis: report on a multicenter open investigation in Portugal. Pharmatherapeutica 1982; 3(3): 157–68.
- Lopes V: Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in out-patients. Curr Med Res Opin 1982; 8(3): 145–149.
- D'Ambrosio E, Casa B, Bompani R: Glucosamine sulphate: a controlled clinical investigation in arthrosis. Pharmatherapeutica 1981; 2(8): 504–508.
- Hamerman D, Smith C, Keiser HD, Graig R: Glycosaminoglycans produced by human synovial cell cultures. Collag Related Res 1982: 313–329.